The discovery of Piezo1 channels as force sensors with roles in the endothelial response to fluid flow has appeared contradictory to earlier work suggesting mediation by a triad of cell adhesion molecules (CD31 and VE-cadherin) and vascular endothelial growth factor receptor 2 (VEGFR2). Here we propose an explanation. Stimulated emission depletion microscopy revealed physical proximity between Piezo1 and CD31 primarily at cell junctions. Förster resonance energy transfer measured by fluorescence lifetime imaging showed that the proteins approached to less than 10 nm. Substitution of a tyrosine residue at the distal Cterminus of CD31 prevented the interaction, suggesting intracellular association. The extracellular N-terminus also interacted, but exclusively at cell junctions. There was proximity between Piezo1 and VE-cadherin but not VEGFR2. Interaction with VE-cadherin was flowdependent, consistent with additional recruitment after flow-sensing. CD31 suppressed mechanical sensitivity of Piezo1 channels and interacted with N-terminal Piezo1 propeller arms implicated in force sensing. The data suggest partnership between Piezo1 and adhesion molecules for sub cellular tuning of force response.
participation in force sensing between cells. CD31 is a 130 kDa protein belonging to type-I membrane glycoprotein and immunoglobulin super-families. It has an extracellular region containing immunoglobulin-like domains, a transmembrane region of one α helix and a cytoplasmic region containing tyrosine regulatory motifs. It is often used as an endothelial cell marker but is expressed and functional also in leukocytes and platelets 12 . VE-cadherin belongs to a large family of transmembrane Ca 2+ -dependent adhesion molecules 14, 15 . It also has an extracellular domain that mediates homotypic interactions and an intracellular regulatory domain, which in this case binds -or -catenin to promote cytoskeletal interaction 14 . An influential study linked CD31 and VE-cadherin to sensing of mechanical force caused by fluid flow and suggested that vascular endothelial growth factor receptor 2 (VEGFR2) was recruited as a third partner, leading to the prominent hypothesis that a CD31/VE-Cadherin/VEGFR2
triad is a key flow sensor 8, 11, 16 . Subsequently another endothelial flow sensing hypothesis emerged because of the discovery of a different protein called Piezo1 [17] [18] [19] [20] [21] [22] . Piezo1 is a 38-pass membrane protein of 286 kDa that assembles as a trimer to form Ca 2+ -permeable nonselective cationic channels [23] [24] [25] [26] . This channel is exquisitely sensitive to membrane tension, activating rapidly as membrane tension rises [26] [27] [28] . Importantly it is also activated by fluid flow [17] [18] [19] [20] [21] [22] , strongly but not uniquely expressed in endothelial cells 17, 28 and required for endothelial responses to force such as cell alignment in the direction of flow and activation of endothelial nitric oxide synthase 17, 20 . It is also implicated in cell junction integrity 29 .
Here we investigated the relationship of the CD31/VE-cadherin/VEGFR2 triad to Piezo1.
of less than 10 nm in some instances ( Figure 1d ). The data suggest close co-localisation of CD31 and Piezo1 particularly at cell-cell junctions.
We therefore investigated if protein interactions occur, using fluorescence lifetime imaging microscopy (FLIM) to quantify Förster Resonance Energy Transfer (FRET). To this end we engineered a donor fluorophore (mTurquoise2) on the C-terminus of Piezo1 and an acceptor fluorophore (SYFP2 or mVenus) on the C-terminus of CD31 (SYFP2), VE-cadherin (mVenus) and VEGFR2 (SYFP2), enabling investigation of cytoplasmic interactions. Expressed alone, Piezo1-mTurquoise2 was primarily perinuclear and endoplasmic reticular in localisation was similar at intracellular sites and cell junctions whereas VE-cadherin interaction was apparently greater at junctions, although there was insufficient power for statistical significance (Supplementary Figure 1) . The data suggest that CD31 and VE-cadherin promote localisation of Piezo1 to junctions and that they physically interact with Piezo1.
To determine if mechanical force affects the sub cellular localisation or interaction we applied preconditioning fluid flow and then, after a static period, a second short pulse of flow. The preconditioning tended to increase junctional relative to intracellular interaction of Piezo1 with CD31 but the second pulse of flow had no further effect (Figure 3a-d) . More striking was that preconditioning enhanced junctional relative to intracellular interaction of Piezo1 with VEcadherin and that the second pulse of flow further increased the junctional interaction ( Figure   3e-g ). There was a hint that flow caused mild junctional interaction between Piezo1 and VEGFR2 but statistical significance was not achieved (Figure 3h-j) . The data suggest that elements of the interaction can be force sensitive.
To further test our hypothesis that cell adhesion molecules interact with Piezo1 we focussed on CD31. Based on previously suggested and predicted functional amino acids in CD31 we selected five C-terminal residues to mutate and investigated the consequences (Figure 4a ).
The interaction was unchanged or potentially slightly reduced by C622A, Y663F, Y690F or S700F ( Figure 4b ,c cf Figure 2e ). Most convincing, however, was that the distal C-terminal mutation Y713F prevented interaction, notably at cell junctions (Figure 4b, c) . Importantly, CD31-Y713F was expressed and localised normally compared with wildtype CD31 ( Figure 4d ). The data support the conclusion that CD31 interacts with Piezo1 by showing that mutation of the single residue Y713F is sufficient to prevent FRET. The data also suggest that interaction occurs intracellularly and that it might be regulated by tyrosine phosphorylation.
We next considered the N-terminal extracellular domain by replacing the transmembrane and cytoplasmic regions of CD31 with a plasma membrane-targeting sequence and locating SYFP2 to the intracellular site to generate CD31-ex-SYFP2 (Figure 5a ). Intensity images of Piezo1-mTurquoise2 and CD31-ex-SYFP2 showed pronounced enrichment at cell junctions ( Figure 5b ). Lifetime analysis showed strong interaction at junctions but no interaction at intracellular sites (Figure 5c -e). The data suggest that the extracellular N-terminus of CD31 also interacts with Piezo1 channels and that this interaction is blocked prior to the CD31 reaching junctional sites.
To investigate if the interaction has functional significance we measured mechanical sensitivity of Piezo1 channels in excised outside-out patches, thus restricting data collection to the surface membrane. Positive pressure steps caused membrane stretch, which activated Piezo1 channels (e.g. Figure 6a ). CD31 shifted the pressure-response curve to the right and reduced its slope (Figure 6b ). To determine how CD31 might reduce the mechanical sensitivity of Piezo1 channels we made C-terminally truncated Piezo1 constructs ( Figure 6c ) and tested their ability to interact with CD31 by co-immunoprecipitation. We found that N-terminal regions of Piezo1, lacking the C-terminal ion pore and CED, were sufficient for interaction ( Figure 6d ).
The data suggest that CD31 interacts with the N-terminal propeller blade structures of Piezo1 channels 23-25 to potentially alter their flexibility and tone down channel response to increases in force.
Discussion
The study suggests that two apparently divergent ideas for endothelial flow sensing -Piezo1 and the CD31 triad -are interrelated. We show evidence of physical proximity detected by super-resolution microscopy techniques and of physical interaction detected by FRET, coimmunoprecipitation and functional effect of over-expressed CD31 on activity of Piezo1 channels in excised membrane patches. Intriguingly we found that the second cell adhesion molecule of the triad -VE-cadherin -also interacts with Piezo1 (in the absence of CD31) and that its interaction has distinctive flow sensitivity. VEGFR2, which is recruited to the triad in response to flow
11
, did not directly interact with Piezo1 as determined by FRET; we hypothesize that it may depend on CD31 or VE-cadherin for efficient association. . Therefore the functional relationship between Piezo1 and CD31 is likely to be two-way, including but not necessarily restricted to: physical interaction of CD31 with Piezo1 channels to alter channel sensitivity; and Ca 2+ entry through Piezo1 channels to activate calpain and therefore modify CD31 and other proteins.
The CD31 triad and its relationship to Piezo1 channels occurs at cell-cell junctions that are likely to be physically hidden from direct impact of fluid flow. This is not to say that they lack importance as mediators of the flow response but the luminal surface of endothelial cells is the more obvious site for impact of fluid flow either directly or via glycocalyx. While the functional significance of CD31 may be restricted to points of cell-to-cell contact, we know that flow sensing Piezo1 channels also exist at the luminal surface because patches of membrane picked from this surface of native endothelium contain such channels
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. These channels may not be associated with CD31 and could therefore be expected to achieve greater mechanical sensitivity.
Overall the data suggest previously unrecognised physical interaction, co-localisation and functional relationship between the Piezo1 force sensing ion channel and cell adhesion 
Methods
Cell lines COS-7 cells were from the American Type Culture Collection (ATCC) and maintained in Dulbecco`s Modified Eagle Media (DMEM) supplemented with 10% FCS, 2 mM L glutamine, 100 U.ml -1 penicillin, 100 µg.ml -1 streptomycin in 5% CO2, 95% air atmosphere.
Cells were sub-cultured upon reaching a surface area density of 80-90% by detaching with 0.5% trypsin. T-REx-293 cells from Thermo Fisher Scientific were conferred with tetracycline inducible overexpression of human Piezo1 18 were maintained in DMEM supplemented with 10% FCS, 2 mM L glutamine,100 U.ml -1 penicillin, 100 µg.ml -1 streptomycin in 5% CO2, 95% air atmosphere. Cells were selected with zeocin (400 μg.ml -1 ) and blasticidin (5 μg.ml -1 ) and induced with tetracycline (100 ng.ml -1 ) for 24 hr. T-REx-293 overexpressing CD31 were generated by seeding at 70% confluency in a 6 well plate. Cells were transfected for 5 hours with 500 ng CD31 plasmid and 0.3% Lipofectamine 2000 (Invitrogen). After 48 hr selection with 5 μg/ml blasticidin began. Single cell lines stably expressing CD31 were isolated.
Constructs and cloning human Piezo1-mTurquoise2 was sub-cloned from human Piezo1- VEGFR2-SYFP2 was sub-cloned from mEmerald-VEGFR2-N1 (Addgene plasmid # 54298;
http://n2t.net/addgene:54298; RRID:Addgene_54298) was a gift from Michael Davidson.
When sequenced mEmerald-VEGFR2-N1 was found to contain a frameshifting CT insertion between residues T1303-A1304 and the single nucleotide polymorphisms (SNP) V297I and H472Q. Site-directed mutagenesis was performed to remove the insertion and correct the used a system comprising an air pressure pump, pump control software, perfusion set (yellow/green) and fluidics unit (Ibidi). Cells were exposed to shear stress of 10 dyn.cm -2 for 24 hr. Flow was stopped for a 30 min rest period after which cells were stimulated with flow (10 dyn.cm -2 , 10 min) and then fixed with 4% paraformaldehyde.
FLIM microscopy Intensity and FLIM images were obtained on an upright LSM710 (Carl Zeiss) microscope with a 40x /1.0 NA, water-dipping objective or 63x/1.40 Oil (Carl Zeiss).
Acceptor intensity images were obtained with excitation at 512 nm using an Argon laser and registered on the Zeiss PMT detectors. Two-photon excitation was provided by Chameleon Co-immunoprecipitation 500 μg of transiently transfected HEK 293 cell lysate (lysis buffer:
10 mM Tris, pH 7.4, 150 mM NaCl, 0.5 mM EDTA, 0.5% Nonidet P40 substitute, 0.1% glycerol containing protease inhibitor cocktail (Sigma)) was incubated with 1 μg anti-HA (Roche, clone 3F10) for at least 4 hr at 4°C, prior to extraction overnight using Protein G agarose (Pierce).
The beads were washed three times with ice-cold lysis buffer and bound proteins eluted using sample buffer (4x SB: 250 mM Tris pH 6.8, 8% SDS, 40% glycerol, 8% β-mercaptoethanol) and heating at 95°C. Samples were loaded on 7% gels and resolved by electrophoresis.
Proteins were transferred to PVDF membranes and labelled overnight with anti-HA (0.01 μg/mL, Roche clone 3F10), anti-VE-Cadherin (0.5 μg.ml 
